Nucleic Acid Amplification Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nucleic Acid Amplification Testing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Polymerase Chain Reaction (PCR) tests, Isothermal Nucleic Acid Amplification Technology (INAAT) tests, Ligase Chain Reaction (LCR) tests)
5.2.2. By Application (Infectious disease testing, Oncology testing, Genetic & mitochondrial disease testing, Others)
5.2.3. By End Use (Hospitals, Central and reference laboratories, Others)
5.2.4. By Region
5.2.5. By Company (2023)
5.3. Product Market Map
5.3.1. By Type
5.3.2. By Application
5.3.3. By End Use
5.3.4. By Region

6. North America Nucleic Acid Amplification Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type (Polymerase Chain Reaction (PCR) tests, Isothermal Nucleic Acid Amplification Technology (INAAT) tests, Ligase Chain Reaction (LCR) tests)
6.2.2. By Application (Infectious disease testing, Oncology testing, Genetic & mitochondrial disease testing, Others)
6.2.3. By End Use (Hospitals, Central and reference laboratories, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Nucleic Acid Amplification Testing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Application
6.3.1.2.3. By End Use
6.3.2. Canada Nucleic Acid Amplification Testing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Application
6.3.2.2.3. By End Use
6.3.3. Mexico Nucleic Acid Amplification Testing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Application
6.3.3.2.3. By End Use

7. Europe Nucleic Acid Amplification Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Polymerase Chain Reaction (PCR) tests, Isothermal Nucleic Acid Amplification Technology (INAAT) tests, Ligase Chain Reaction (LCR) tests)
7.2.2. By Application (Infectious disease testing, Oncology testing, Genetic & mitochondrial disease testing, Others)
7.2.3. By End Use (Hospitals, Central and reference laboratories, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Nucleic Acid Amplification Testing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Application
7.3.1.2.3. By End Use
7.3.2. United Kingdom Nucleic Acid Amplification Testing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Application
7.3.2.2.3. By End Use
7.3.3. France Nucleic Acid Amplification Testing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Application
7.3.3.2.3. By End Use
7.3.4. Italy Nucleic Acid Amplification Testing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Application
7.3.4.2.3. By End Use
7.3.5. Spain Nucleic Acid Amplification Testing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Application
7.3.5.2.3. By End Use

8. Asia-Pacific Nucleic Acid Amplification Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Polymerase Chain Reaction (PCR) tests, Isothermal Nucleic Acid Amplification Technology (INAAT) tests, Ligase Chain Reaction (LCR) tests)
8.2.2. By Application (Infectious disease testing, Oncology testing, Genetic & mitochondrial disease testing, Others)
8.2.3. By End Use (Hospitals, Central and reference laboratories, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Nucleic Acid Amplification Testing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Application
8.3.1.2.3. By End Use
8.3.2. Japan Nucleic Acid Amplification Testing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Application
8.3.2.2.3. By End Use
8.3.3. India Nucleic Acid Amplification Testing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Application
8.3.3.2.3. By End Use
8.3.4. Australia Nucleic Acid Amplification Testing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Application
8.3.4.2.3. By End Use
8.3.5. South Korea Nucleic Acid Amplification Testing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Application
8.3.5.2.3. By End Use
9. South America Nucleic Acid Amplification Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Polymerase Chain Reaction (PCR) tests, Isothermal Nucleic Acid Amplification Technology (INAAT) tests, Ligase Chain Reaction (LCR) tests)
9.2.2. By Application (Infectious disease testing, Oncology testing, Genetic & mitochondrial disease testing, Others)
9.2.3. By End Use (Hospitals, Central and reference laboratories, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Nucleic Acid Amplification Testing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Application
9.3.1.2.3. By End Use
9.3.2. Argentina Nucleic Acid Amplification Testing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Application
9.3.2.2.3. By End Use
9.3.3. Colombia Nucleic Acid Amplification Testing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Application
9.3.3.2.3. By End Use
10. Middle East and Africa Nucleic Acid Amplification Testing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type (Polymerase Chain Reaction (PCR) tests, Isothermal Nucleic Acid Amplification Technology (INAAT) tests, Ligase Chain Reaction (LCR) tests)
10.2.2. By Application (Infectious disease testing, Oncology testing, Genetic & mitochondrial disease testing, Others)
10.2.3. By End Use (Hospitals, Central and reference laboratories, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Nucleic Acid Amplification Testing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Application
10.3.1.2.3. By End Use
10.3.2. Saudi Arabia Nucleic Acid Amplification Testing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Application
10.3.2.2.3. By End Use
10.3.3. UAE Nucleic Acid Amplification Testing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Application
10.3.3.2.3. By End Use
10.3.4. Kuwait Nucleic Acid Amplification Testing Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Type
10.3.4.2.2. By Application
10.3.4.2.3. By End Use

11. Market Dynamics
11.1. Drivers
11.2. Challenges

12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Porter’s Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.6. SWOT Analysis
14.6.1. F Hoffmann-La Roche AG
14.6.2. Becton Dickinson & Co
14.6.3. Danaher Corp
14.6.4. Abbott Laboratories Inc
14.6.5. Illumina Inc
14.6.6. Siemens Healthineers AG
14.6.7. bioM?rieux SA
14.6.8. Novartis AG
14.6.9. Bio-Rad Laboratories Inc
14.6.10. Seegene Inc

15. Strategic Recommendations

16. About Us & Disclaimer